A Win Against Breast Cancer Patient assistance programs offer real patients life-changing benefits Situation In December 2018, Marcia Cortis was diagnosed with HER2-positive breast cancer. Her doctors caught it early, but the road to recovery was still ahead. She wouldn’t need a typical chemotherapy treatment, but she did need Herceptin®, a therapy for HER2-positive breast cancer. Marcia’s University of Missouri Health Care doctors set her up for treatment every three weeks with Herceptin. Not knowing the cost, Marcia of course followed her doctors’ orders. Sticker shock At $48,000 a dose (before insurance), Herceptin is an expensive and important life-saving drug. While Marcia is covered under her Medicare Advantage plan, the resulting cost after each treatment — the amount

Join for free to read